Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Adjusting your budget mid month can be simple. Explore these quick tips to make the process easier.
22,217 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Rising interest-rate expectations are shifting as traders weigh the impact of potential policy shifts. A Trump-led ea...
President Trump reaffirms sanctions on Iran, blocking relief talks as oil prices retreat below $89 per barrel. Market...
Scotiabank announces the acquisition of Maple Financial Holdings, owner of MapleMark Bank, to bolster its U.S. mortga...
Crypto millionaire growth accelerates in 2026 as ETFs lure institutions and major tokens attract capital. Analysts we...
Peter Thiel's AI warning collides with rising demand for storytellers, prompting a reassessment of career paths and p...
As AI enthusiasm cools, investors pivot to hard assets. New data show demand data center power rising faster than exp...
Lenders push automation and AI in a bid to speed closings, but costs rise and internal handoffs persist. Analysts wei...
This article unpacks the fibk 2026 earnings transcript to reveal what the quarter’s numbers mean for investors. You’l...
BWLP’s Q1 2026 results offer a window into fleet utilization, charter rates, and balance-sheet moves. This guide brea...
The OECD's June 2026 outlook warns of lasting damage to potential output from a protracted energy crisis, outlining t...
As Anthropic prepares an IPO, history warns that sky-high private valuations rarely translate into smooth public-mark...